Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes - CISMeF
Anti-Glypican 3-scFvGC33-CAR-expressing T LymphocytesNCIt concept
Preferred Label : Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes;
NCIt synonyms : Autologous GPC3-CAR T Cells; Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells; Autologous GAP T Cells; GPC3-CAR Transduced Autologous T Cells; Anti-GPC3-scFvGC33-CAR Autologous T Lymphocytes; Glypican 3-specific Chimeric Antigen Receptor-expressing Autologous T Cells;
NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to express
a chimeric antigen receptor (CAR) containing a single chain variable fragment (scFv)
derived from the anti-glypican-3 (GPC3) monoclonal antibody GC33 (scFvGC33), with
potential immunostimulating and antineoplastic activities. Upon administration, anti-GPC3-scFvGC33-CAR
autologous T-lymphocytes specifically target and bind to GPC3-expressing tumor cells,
resulting in tumor cell lysis. GPC3, a heparan sulfate proteoglycan and a member of
the glypican family, is overexpressed on certain tumor cell types while minimally
expressed in normal, healthy cells.. GPC3 plays an important role in cellular proliferation
and differentiation.;